NovaBridge Biosciences (NBP) Tax Provisions (2020)
NovaBridge Biosciences (NBP) reported Tax Provisions of -$1.8 million for Q4 2020.
NovaBridge Biosciences (NBP) Tax Provisions (2020) Analysis & Trends
NovaBridge Biosciences (NBP) has 1 years of Tax Provisions data on file, last reported at -$1.8 million in Q4 2020.
- Tax Provisions for Q4 2020 came in at -$1.8 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was -$1.8 million (changed N/A YoY), and the FY2022 annual result was -$103000.0, up 79.19% from the prior year.
- Tax Provisions was little changed at -$1.8 million in Q4 2020 per NBP's latest filing.
- Over five years, Tax Provisions peaked at -$1.8 million in Q4 2020 and troughed at -$1.8 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -1.85 Mn |